-
HCA, Harvard Pilgrim, UC Irvine partner on research to prevent HAIs
An antibiotic ointment administered through the nose is effective in protecting critically ill patients in the ICU from Staphylococcus aureus infections, according to an Oct. 10 HCA Healthcare news release. -
Bristol Myers Squibb to buy cancer drugmaker for $5.8B
Bristol Myers Squibb, one of the world's largest pharmaceutical companies, plans to acquire oncology drugmaker Mirati Therapeutics for up to $5.8 billion. -
CarelonRx: Collaboration between payers, specialty pharmacies can help people lead healthier lives
We all know someone affected by a complex illness. Cancer. Crohn's disease. Multiple sclerosis. -
California is 1st state to require pharmacists to report errors
California is the first state to require pharmacists to report every prescription mistake. -
Walgreens walkout enters last day: 5 notes
After seeing success from CVS pharmacy workers calling out of work over staffing concerns in Kansas City, Walgreens employees organized a walkout — but it's unclear whether the scattered labor action will result in change. -
Employer coverage of weight-loss drugs set to double in 2024
Forty-three percent of employers plan to cover weight loss drugs in 2024, nearly double the proportion of employers that cover them now, according to newly released survey findings from Accolade. -
Mark Cuban's pharmacy racks up collaborators
Nearly two years after Mark Cuban launched a mail-order pharmacy with low-cost medications, the entrepreneur and "Shark Tank" star has secured more than a dozen collaborators. -
DEA, HHS issue 2nd extension of controlled substances via telehealth
The U.S. Drug Enforcement Agency is, for a second time, extending clinicians' ability to prescribe controlled substances using telehealth services, according to a revised rule the agency published. -
5 drugs now in shortage
Since mid-September, drugmakers have reported five new drug shortages, including medications for lung cancer, hypertension and eye infections. -
Walgreens pharmacists plan walkout
An unclear number of Walgreens pharmacies might close Oct. 9-11 after pharmacists shared plans through social media apps, emails and fliers to stage a walkout, according to CNN. -
Minnesota system buys independent pharmacy
Staples, Minn.-based Lakewood Health System is acquiring a local pharmacy. -
Cancer drug study partially halted after patient death
After a study participant died from a severe and rare inflammatory syndrome, the FDA placed a partial clinical hold on a France-based drugmaker's cancer drug trial. -
Mark Cuban's drug company, caregiver app team up
Mark Cuban Cost Plus Drug Co. recently penned a deal with Avanlee Care, which runs an app designed to help caregivers for elderly patients. -
Walmart: Ozempic leading to fewer food purchases
Walmart is experiencing less food demand from individuals taking GLP-1s such as Ozempic or Wegovy, Bloomberg reported Oct. 4. -
Cancer drug shortage slightly eases
The national shortage of multiple cancer therapies is marginally improving compared to early summer, according to an Oct. 5 update from the National Comprehensive Cancer Network. -
Kaiser closes some outpatient pharmacies amid strike
As about 75,000 Kaiser Permanente workers strike in six states, the Oakland, Calif.-based system has temporarily closed at least 18 outpatient pharmacies across four states. -
FDA probes phony Ozempic schemes
The FDA has started investigating schemes to sell counterfeit versions of Ozempic to unsuspecting pharmacies, according to an Oct. 4 industry alert obtained by CBS News. -
Study links Ozempic with stomach paralysis
The active ingredients of Ozempic, Wegovy and Saxenda are associated with stomach paralysis, according to a study published Oct. 5 in JAMA. -
AbbVie's oral cancer drug trial shows it may provide 'anti-tumor immunity'
Research for a new oral cancer medication from pharmaceutical giant AbbVie yielded positive preclinical data that shows it "enhances anti-tumor immunity," according to an Oct. 4 news release. -
Moderna to move forward with combo flu, COVID-19 shot
Moderna is moving forward with plans to develop a combination vaccine for flu and COVID-19 after early-stage studies yielded positive results, the company said Oct. 3.
Page 43 of 50